Literature DB >> 27602182

Near complete genome sequence of the animal feed probiotic, Bacillus amyloliquefaciens H57.

Benjamin J Schofield1, Adam Skarshewski2, Nancy Lachner2, Diane Ouwerkerk3, Athol V Klieve4, Peter Dart1, Philip Hugenholtz2.   

Abstract

Bacillus amyloliquefaciens H57 is a bacterium isolated from lucerne for its ability to prevent feed spoilage. Further interest developed when ruminants fed with H57-inoculated hay showed increased weight gain and nitrogen retention relative to controls, suggesting a probiotic effect. The near complete genome of H57 is ~3.96 Mb comprising 16 contigs. Within the genome there are 3,836 protein coding genes, an estimated sixteen rRNA genes and 69 tRNA genes. H57 has the potential to synthesise four different lipopeptides and four polyketide compounds, which are known antimicrobials. This antimicrobial capacity may facilitate the observed probiotic effect.

Entities:  

Keywords:  Antimicrobials; Bacillus amyloliquefaciens; Illumina; Probiotic

Year:  2016        PMID: 27602182      PMCID: PMC5012032          DOI: 10.1186/s40793-016-0189-z

Source DB:  PubMed          Journal:  Stand Genomic Sci        ISSN: 1944-3277


Introduction

been taxonomically classified as part of the group. Members of this group share substantial morphological similarities and near identical (98.1 %–99.8 %) 16S rRNA gene sequences [1]. Other members of the group include , , , , , , and the subgroup. The production of bioactive metabolites, the ability to form spores and a lack of pathogenicity make members of the group ideal candidates for use as probiotics. Strains of synthesise non-ribosomal bioactive lipopeptides such as surfactin, fengycin, bacillomycin D and members of the iturin family [2-4]. These lipopeptides have demonstrated activity as antimicrobials and inhibit a wide range of bacterial and fungal pathogens [3, 5]. The strain H57 (H57 hereafter) was first isolated in the search for a biological control agent to prevent fungal spoilage of hay [6]. Due to its spore forming ability and production of antimicrobial compounds, H57 was revealed as the best candidate of a panel of isolates for commercialisation as a spoilage control agent under the product name HayRite™. Importantly, sheep and cattle fed on HayRite™ treated feed showed an increase in digestibility and nitrogen retention leading to increased live weight gain [6]. This new development into the potential of H57 to act as a probiotic has led to further investigation of this strain. Here, we present a summary description of the classification and features of H57, along with a sequencing description and annotation summary. The availability of a genome sequence for H57 will facilitate research into the probiotic effects observed in animals treated with this bacterium.

Organism information

Classification and features

A near-complete 16S rRNA gene was identified in the H57 genome, which by BLAST [7] is most closely related (99 % identical) to other strains including FZB42 (; acc. NR075005.1), HPCAQB14 (acc. KF861603.1) and SB 3200 (acc. GU191911.1). Comparison of the average read coverage of the genome and 16S rRNA gene, suggests that H57 has 13 copies of the rRNA operon. A concatenated alignment of 99 single copy marker genes obtained from publicly available genomes using HMMER [8] confirmed the classification of strain H57 as a member of the species (Fig. 1).
Fig. 1

Maximum likelihood tree showing the alignment of H57 with other Bacillus genomes. Alignment was performed using HMMER [8] whilst maximum likelihood was inferred using FastTree version 2.7.7 [32]. The inferred tree was visualised using ARB version 6.0.2 [33]. Bar: 0.1 substitutions per nucleotide position

Maximum likelihood tree showing the alignment of H57 with other Bacillus genomes. Alignment was performed using HMMER [8] whilst maximum likelihood was inferred using FastTree version 2.7.7 [32]. The inferred tree was visualised using ARB version 6.0.2 [33]. Bar: 0.1 substitutions per nucleotide position H57 is a Gram-positive rod shaped bacterium averaging 2.5 μm in length and 1 μm in width (Fig. 2d). It is an aerobic spore forming bacterium that is motile with peritrichous flagella. H57 spores are centrally located and average 1.25 μm in length (Fig. 2b). Optimum growth occurs at a temperature of 29 °C and pH 7.0 (Table 1). The colony morphology of strain H57 is circular convex with undulate margins. When grown on a nutrient agar plate, colonies are an off-white colour as shown in Fig. 2c.
Fig. 2

Cellular and colony morphology of B. amyloliquefaciens H57. a Vegetative H57 cells at 1000x magnification captured with a Nikon DS-Ri1 camera attached to a Nikon Eclipse 80i microscope under phase contrast. b H57 spores at 1000x magnification captured with a Leica DFC 500 camera attached to a Leica DM5500B compound microscope with Nomarski differential interference contrast. c Pure culture of H57 grown on nutrient agar plate. d Electron microscope image of a vegetative H57 cell showing numerous peritrichous flagella, negatively stained with phosphotungstic acid

Table 1

Classification and general features of Bacillus amyloliquefaciens strain H57 [10]

MIGS IDPropertyTermEvidence codea
ClassificationDomain Bacteria TAS [34]
Phylum Firmicutes TAS [3537]
Class Bacilli TAS [38, 39]
Order Bacillales TAS [40, 41]
Family Bacillaceae TAS [40, 42]
Genus Bacillus TAS [40, 43, 44]
Species Bacillus amyloliquefaciens TAS [4547]
Strain: H57
Gram stainPositiveIDA
Cell shapeRod/chainsIDA
MotilityMotileIDA
SporulationSporulatingIDA
Temperature rangeMesophilicIDA
Optimum temperature29 °CIDA
pH range; Optimum5-9; 7IDA
Carbon sourceGlucose, fructose, mannitol, sucrose, trehaloseIDA
MIGS-6HabitatLeaves of Medicago sativa TAS [6]
MIGS-6.3SalinityUp to 6 % (w/v)IDA
MIGS-22Oxygen requirementAerobeIDA
MIGS-15Biotic relationshipSymbiotic (beneficial)TAS [6]
MIGS-14PathogenicityNon-pathogenNAS
MIGS-4Geographic locationGatton, QLD, AustraliaIDA
MIGS-5Sample collection2001IDA
MIGS-4.1Latitude27° 32' 24'' SIDA
MIGS-4.2Longitude152° 20' 24'' EIDA
MIGS-4.4Altitude89 mIDA

a Evidence codes - IDA Inferred from Direct Assay, TAS Traceable Author Statement (i.e., a direct report exists in the literature), NAS Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project [48]

Cellular and colony morphology of B. amyloliquefaciens H57. a Vegetative H57 cells at 1000x magnification captured with a Nikon DS-Ri1 camera attached to a Nikon Eclipse 80i microscope under phase contrast. b H57 spores at 1000x magnification captured with a Leica DFC 500 camera attached to a Leica DM5500B compound microscope with Nomarski differential interference contrast. c Pure culture of H57 grown on nutrient agar plate. d Electron microscope image of a vegetative H57 cell showing numerous peritrichous flagella, negatively stained with phosphotungstic acid Classification and general features of Bacillus amyloliquefaciens strain H57 [10] a Evidence codes - IDA Inferred from Direct Assay, TAS Traceable Author Statement (i.e., a direct report exists in the literature), NAS Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project [48]

Genome sequencing information

Genome project history

Strain H57 was selected for sequencing due to its ability to act as a probiotic in agricultural animals. The draft genome was deposited in GenBank under the accession number LMUC00000000. Genome sequencing and assembly was performed at the Australian Centre for Ecogenomics, The University of Queensland. Gene annotation was performed using the AnnotateM script [9]. A summary of the project is shown in Table 2 using MIGS version 2.0 [10] criteria.
Table 2

Project information

MIGS IDPropertyTerm
MIGS 31Finishing qualityDraft
MIGS 28Libraries usedIllumina paired end library (256 bp insert size)
MIGS 29Sequencing platformsIllumina MiSeq
MIGS 31.2Fold coverage49×
MIGS 30AssemblersSpades 3.0.0.
MIGS 32Gene calling methodPROKKA
Locus tagGa0082361
Genbank IDLMUC00000000
GenBank Date of Release04/04/2016
GOLD IDGa0082361
BIOPROJECTPRJNA300579
MIGS 13Source material identifier Bacillus amyloliquefaciens H57
Project relevanceProbiotic, Agriculture
Project information

Growth conditions and genomic DNA preparation

Genomic DNA of H57 was isolated from a freeze-dried product of H57 spores combined with sodium bentonite (1:1). DNA was extracted from the H57 spores using the ‘Repeated Bead-beating and Column Extraction’ method described by Yu and Forster (2005) [11]. In brief, 0.1 g of sporulated product was added to 1 mL of lysis buffer (2.9 % NaCl, 0.6 % Tris, 0.05 M EDTA pH 8.0 and 4 % SDS) in a cryotube containing 0.5 g zirconia beads (BioSpec Products Inc., Bartlesville, USA). The sample was then homogenised in a mini bead beater 16 (BioSpec Products Inc., Bartlesville, USA) for 2 cycles of 3 min. Between cycles the samples were incubated for 15 min at 70 °C, centrifuged (13,200 rpm for 5 min at 4 °C) and supernatant transferred to a fresh tube. Following bead beating further extraction was performed on the supernatant using the QIAGEN QIAmp DNA Mini Kit as per kit instructions (QIAGEN, Doncaster, VIC).

Genome sequencing and assembly

The genome of H57 was sequenced on an Illumina MiSeq sequencing platform (Illumina, Inc. San Diego, CA). DNA libraries were prepared using the Nextera® XT DNA Library Preparation Kit (Illumina, San Diego, CA) according to the manufacturer’s instructions. An input of 1 ng was used to prepare DNA libraries, which was then cleaned using Agencourt AMPure XP beads (Beckman Coulter, Brea, CA, USA). The purified PCR product was then size selected for amplicons with a size between 300 bp and 800 bp. Illumina paired-end sequencing was performed, producing a total of 1,351,526 reads. Primer and adaptor sequences were removed using Trimmomatic v0.32 [12] resulting in an average read length of 256 bp. Reads were assembled using SPAdes 3.0.0. [13]. The H57 genome was obtained in 16 contigs ranging in size from 701,147 bp to 10,158 bp with a combined length of 3,958,833 bp. Genome completeness and contamination was estimated using CheckM version 1.0.0, indicating that the genome was near complete (99.51 %) with no detectable contamination (0 %) [14].

Genome annotation

Gene annotation was achieved using a combination of protein databases via AnnotateM Version 6.0 [9]. Open reading frames were initially generated using PROKKA [15]. The resulting protein sequence was then searched against the IMG, Uniref, COG, PFAM and TIGRfam databases [16-20] to identify homologous genes. The software ProteinOrtho [21] was used to identify orthologous genes to other known strains for further comparison. Genes unique to H57 were compared against the KEGG gene database [22] to identify metabolic functions.

Genome properties

The draft genome assembly of H57 consists of sixteen contigs totalling 3,958,833 bp and a G + C content of 46.42 %, which is likely a slight underestimate of its genome size due to unresolved collapsed repeats, primarily rRNA operons (Table 3). With a coding region of 3,549,557 bp, this assembly represents a total of 3,945 ORFs. Of those genes, 3,836 encode proteins and the remainder encode sixteen rRNAs (7 × 5S, 7 × 16S and 2 × 23S), 69 tRNAs and 24 other RNA genes (Table 3). Of the annotated genes, the majority were assigned a putative function (80.66 %) with 69.81 % assigned into Clusters of Orthologous Groups, presented in Table 4. Of the 3,945 ORFs in the H57 genome, 3,751 were inferred to be orthologous to other strains, including strains CC178, DSM7, XH7, TF28, Y2, IT-45, LFB112 and strains UCMB5113, FZB42, NAU-B3, YAU B9601-Y2, and TrigoCor1448. Of the 194 genes unique to H57, several appear to be involved in the degradation of aromatic compounds, more specifically the breakdown of 4-hydroxyphenylacetic acid.
Table 3

Genome statistics

AttributeValue% of Total
Genome size (bp)3,958,833100.00
DNA coding (bp)3,549,55789.66
DNA G + C (bp)1,837,54946.42
DNA scaffolds16100.00
Total genes3,945100.00
Protein coding genes3,83697.24
RNA genes1092.76
Pseudo genes00.00
Genes with internal clusters3879.81
Genes with function prediction3,18280.66
Genes assigned to COGs2,75469.81
Genes with Pfam domains3,36485.27
Genes with signal peptides1914.84
Genes with transmembrane helices1,04626.51
CRISPR repeats00.00
Table 4

Number of genes associated with general COG functional categories

CodeValue%agea Description
J1363.48Translation, ribosomal structure and biogenesis
A00.00RNA processing and modification
K892.23Transcription
L952.43Replication, recombination and repair
B10.03Chromatin structure and dynamics
D220.56Cell cycle control, Cell division, chromosome partitioning
V170.44Defence mechanisms
T581.48Signal transduction mechanisms
M972.48Cell wall/membrane biogenesis
N401.02Cell motility
U370.95Intracellular trafficking and secretion
O641.64Posttranslational modification, protein turnover, chaperones
C922.35Energy production and conversion
G1092.79Carbohydrate transport and metabolism
E1604.09Amino acid transport and metabolism
F621.59Nucleotide transport and metabolism
H932.38Coenzyme transport and metabolism
I531.36Lipid transport and metabolism
P932.38Inorganic ion transport and metabolism
Q300.77Secondary metabolites biosynthesis, transport and catabolism
R2035.19General function prediction only
S2386.09Function unknown
-216955.49Not in COGs

aThe total is based on the total number of protein coding genes in the genome

Genome statistics Number of genes associated with general COG functional categories aThe total is based on the total number of protein coding genes in the genome

Insights from the genome sequence

Comparative analysis of the H57 genome indicates that its central metabolism is consistent with other strains of . The presence of a complete TCA cycle and electron transport chain indicates the potential for aerobic respiration. H57 has a narGHJI operon and the transcriptional regulator fnr, suggesting that it is also capable of growing anaerobically using nitrate as an electron acceptor [23]. This capability would be required for H57 to grow in anoxic environments. The genome of H57 also encodes a number of enzymes involved in carbohydrate metabolism. A search against the carbohydrate-active enzyme database [24] reveals that H57 is dominant in glycoside hydrolase families 1, 43 and 13 (Table 5). The GH 1 and GH 43 families comprise enzymes that degrade the various sugar monomers of hemicellulose. This suggests that H57 may contribute to breaking down the less fibrous components of the plant cell wall. The abundance of GH 13 enzymes, which are a family of α-amylases, suggests that H57 also contributes to the breakdown of starch. The presence of these carbohydrate-activated enzymes alludes to the notion that H57 may assist in the digestion of animal feeds by breaking down certain polysaccharides of the plant cell wall.
Table 5

Carbohydrate activated enzyme profile of glycoside hydrolases in H57

FamilyKnown activity%a
GH16Xyloglucan, keratan-sulfate, endo-1,4-β-galactosidase, endo-1,3- β-glucanase, and others2.5
GH4Maltose-6-phosphate glucosidase, α-glucosidase, α-galactosidase, and others7.5
GH5Chitosanase, β-mannosidase, cellulase, glucan 1,3-β-glucosidase, and others2.5
GH13α-amylase, pullulanase, cyclomaltodextrin glucanotransferase and others10
GH11Xylanase2.5
GH23Lysozyme type G and peptidoglycan lyase2.5
GH3β-glucosidase, xylan 1,4-β-xylosidase, β-N-acetylhexosaminidase, and others2.5
GH126Other2.5
GH18Chitinase, endo-β-N-acetylglucosaminidase, and others7.5
GH26β-mannanase and β-1,3-xylanase2.5
GH53Endo-β-1,4-galactanase2.5
GH51α-L-arabinofuranosidase and endoglucanase5
GH1β-glucosidase, β-galactosidase, β-mannosidase, and others12.5
GH73Peptidoglycan hydrolase with endo-β-N-acetylglucosaminidase specificity5
GH30Glucosylceramidase, β-1,6-glucanase, β-xylosidase5
GH32Endo-inulinase, endo-levanase, exo-inulinase, and others7.5
GH46Chitosanase2.5
GH109α-N-acetylgalactosaminidase5
GH43Arabinases and xylosidases10
GH68Levansucrase, β-fructofuranosidase and inulosucrase2.5
Total GH hits:40
Total ORFs:3,828
% GH ORFs:1.04

aPercentage of total GH hits

Carbohydrate activated enzyme profile of glycoside hydrolases in H57 aPercentage of total GH hits Consistent with observed anti-fungal activity, the H57 genome encodes a broad range of antimicrobial compounds. These include genes for non-ribosomal synthesis of antimicrobial lipopeptides such as surfactin (srfABCD), iturin (ituABCD), bacillomycin D (bmyABC) and fengycin (fenABCDE). Surfactin is capable of inhibiting a wide range of microorganisms due to its ability to insert itself into the cell wall creating ion pores [25]. Bacillomycin D, iturin and fengycin all have demonstrated antifungal properties primarily based on their ability to disrupt the fungal cell wall [26-28]. The genes for the expression of antibiotic polyketides are also present on the H57 genome. These include the operons mlnABCDEFGHI, dfnABCDEFGHIJ and baeEDLMNJRS, which encode macrolactin, difficidin and bacillaene respectively. These compounds inhibit a wide range of microorganisms acting chiefly on preventing protein synthesis [29-31].

Conclusions

The ~3.96 Mbp genome of H57 reveals the basis of its antimicrobial nature and potential to survive and reproduce in anoxic animal gastrointestinal tracts. In common with other strains, H57 encodes a wide range of antimicrobial compounds that explain its effectiveness as a biocontrol agent for fungi and other feed spoilage organisms. The production of these compounds may also contribute to the observed probiotic effect by inhibiting potentially pathogenic organisms creating a healthier microbial ecosystem.
  32 in total

1.  ARB: a software environment for sequence data.

Authors:  Wolfgang Ludwig; Oliver Strunk; Ralf Westram; Lothar Richter; Harald Meier; Arno Buchner; Tina Lai; Susanne Steppi; Gangolf Jobb; Wolfram Förster; Igor Brettske; Stefan Gerber; Anton W Ginhart; Oliver Gross; Silke Grumann; Stefan Hermann; Ralf Jost; Andreas König; Thomas Liss; Ralph Lüssmann; Michael May; Björn Nonhoff; Boris Reichel; Robert Strehlow; Alexandros Stamatakis; Norbert Stuckmann; Alexander Vilbig; Michael Lenke; Thomas Ludwig; Arndt Bode; Karl-Heinz Schleifer
Journal:  Nucleic Acids Res       Date:  2004-02-25       Impact factor: 16.971

2.  Optimization of antimicrobial activity of surfactin and polylysine against Salmonella enteritidis in milk evaluated by a response surface methodology.

Authors:  Xianqing Huang; Jianghua Suo; Yanhong Cui
Journal:  Foodborne Pathog Dis       Date:  2011-03       Impact factor: 3.171

3.  Prokka: rapid prokaryotic genome annotation.

Authors:  Torsten Seemann
Journal:  Bioinformatics       Date:  2014-03-18       Impact factor: 6.937

4.  Conformational analyses of bacillomycin D, a natural antimicrobial lipopeptide, alone or in interaction with lipid monolayers at the air-water interface.

Authors:  Mehmet Nail Nasir; Françoise Besson
Journal:  J Colloid Interface Sci       Date:  2012-08-17       Impact factor: 8.128

5.  Structural and functional characterization of gene clusters directing nonribosomal synthesis of bioactive cyclic lipopeptides in Bacillus amyloliquefaciens strain FZB42.

Authors:  Alexandra Koumoutsi; Xiao-Hua Chen; Anke Henne; Heiko Liesegang; Gabriele Hitzeroth; Peter Franke; Joachim Vater; Rainer Borriss
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

6.  Bacillus velezensis is a later heterotypic synonym of Bacillus amyloliquefaciens.

Authors:  Li-Ting Wang; Fwu-Ling Lee; Chun-Ju Tai; Hsiao-Ping Kuo
Journal:  Int J Syst Evol Microbiol       Date:  2008-03       Impact factor: 2.747

7.  The minimum information about a genome sequence (MIGS) specification.

Authors:  Dawn Field; George Garrity; Tanya Gray; Norman Morrison; Jeremy Selengut; Peter Sterk; Tatiana Tatusova; Nicholas Thomson; Michael J Allen; Samuel V Angiuoli; Michael Ashburner; Nelson Axelrod; Sandra Baldauf; Stuart Ballard; Jeffrey Boore; Guy Cochrane; James Cole; Peter Dawyndt; Paul De Vos; Claude DePamphilis; Robert Edwards; Nadeem Faruque; Robert Feldman; Jack Gilbert; Paul Gilna; Frank Oliver Glöckner; Philip Goldstein; Robert Guralnick; Dan Haft; David Hancock; Henning Hermjakob; Christiane Hertz-Fowler; Phil Hugenholtz; Ian Joint; Leonid Kagan; Matthew Kane; Jessie Kennedy; George Kowalchuk; Renzo Kottmann; Eugene Kolker; Saul Kravitz; Nikos Kyrpides; Jim Leebens-Mack; Suzanna E Lewis; Kelvin Li; Allyson L Lister; Phillip Lord; Natalia Maltsev; Victor Markowitz; Jennifer Martiny; Barbara Methe; Ilene Mizrachi; Richard Moxon; Karen Nelson; Julian Parkhill; Lita Proctor; Owen White; Susanna-Assunta Sansone; Andrew Spiers; Robert Stevens; Paul Swift; Chris Taylor; Yoshio Tateno; Adrian Tett; Sarah Turner; David Ussery; Bob Vaughan; Naomi Ward; Trish Whetzel; Ingio San Gil; Gareth Wilson; Anil Wipat
Journal:  Nat Biotechnol       Date:  2008-05       Impact factor: 54.908

8.  Proteinortho: detection of (co-)orthologs in large-scale analysis.

Authors:  Marcus Lechner; Sven Findeiss; Lydia Steiner; Manja Marz; Peter F Stadler; Sonja J Prohaska
Journal:  BMC Bioinformatics       Date:  2011-04-28       Impact factor: 3.169

9.  The COG database: an updated version includes eukaryotes.

Authors:  Roman L Tatusov; Natalie D Fedorova; John D Jackson; Aviva R Jacobs; Boris Kiryutin; Eugene V Koonin; Dmitri M Krylov; Raja Mazumder; Sergei L Mekhedov; Anastasia N Nikolskaya; B Sridhar Rao; Sergei Smirnov; Alexander V Sverdlov; Sona Vasudevan; Yuri I Wolf; Jodie J Yin; Darren A Natale
Journal:  BMC Bioinformatics       Date:  2003-09-11       Impact factor: 3.169

10.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937

View more
  5 in total

1.  Avian intestinal ultrastructure changes provide insight into the pathogenesis of enteric diseases and probiotic mode of action.

Authors:  Shaniko Shini; R Claire Aland; Wayne L Bryden
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

Review 2.  Effect of the Inclusion of Bacillus spp. in Growing-Finishing Pigs' Diets: A Meta-Analysis.

Authors:  Manuel Gonzalez-Ronquillo; Daniela Villegas-Estrada; Lizbeth E Robles-Jimenez; Ricardo A Garcia Herrera; Vanessa L Villegas-Vázquez; Einar Vargas-Bello-Pérez
Journal:  Animals (Basel)       Date:  2022-09-01       Impact factor: 3.231

3.  Mechanism of Antibacterial Activity of Bacillus amyloliquefaciens C-1 Lipopeptide toward Anaerobic Clostridium difficile.

Authors:  Jia Lv; Rong Da; Yue Cheng; Xiaohong Tuo; Jie Wei; Kaichong Jiang; Adediji Omolade Monisayo; Bei Han
Journal:  Biomed Res Int       Date:  2020-03-03       Impact factor: 3.411

Review 4.  A Review on the Biotechnological Applications of the Operational Group Bacillus amyloliquefaciens.

Authors:  Mohamad Syazwan Ngalimat; Radin Shafierul Radin Yahaya; Mohamad Malik Al-Adil Baharudin; Syafiqah Mohd Yaminudin; Murni Karim; Siti Aqlima Ahmad; Suriana Sabri
Journal:  Microorganisms       Date:  2021-03-17

5.  Pellets Inoculated with Bacillus amyloliquefaciens H57 Modulates Diet Preference and Rumen Factors Associated with Appetite Regulation in Steers.

Authors:  Thi Thuy Ngo; Nguyen N Bang; Peter Dart; Matthew Callaghan; Athol Klieve; David McNeill
Journal:  Animals (Basel)       Date:  2021-12-04       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.